Effectiveness of drugs to prevent hepatitis among patients receiving chemotherapy
Wednesday, December 17, 2014 - 01:01
in Health & Medicine
Among patients with lymphoma undergoing a certain type of chemotherapy, receiving the antiviral drug entecavir resulted in a lower incidence of hepatitis B virus (HBV)-related hepatitis and HBV reactivation, compared with the antiviral drug lamivudine, according to a study.